Tralokinumab (IL13) - Research Grade Biosimilar
Product Specifications
Background
Tralokinumab is under investigation for the treatment of Alopecia Areata. Tralokinumab has been investigated for the treatment of Asthma.
Immunogen
Homo sapiens / IL13 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-lambda
NCBI Organism
Homo sapiens
Other Product Names
CAT-354
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6404404 1.0 µg DNA
MGC114483 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
MBS6389758-01 0.1 mL
PLEKHG4 (Puratrophin-1, Pleckstrin Homology Domain-containing Family G Member 4, PH Domain-containing Family G Member 4, Purkinje Cell Atrophy-associated Protein 1, PRTPHN1, ARHGEF44, DKFZp434I216, DKFZP434I216, SCA4) APC
Sign In for Pricing
View Details MBS6389758-02 5x 0.1 mL
PLEKHG4 (Puratrophin-1, Pleckstrin Homology Domain-containing Family G Member 4, PH Domain-containing Family G Member 4, Purkinje Cell Atrophy-associated Protein 1, PRTPHN1, ARHGEF44, DKFZp434I216, DKFZP434I216, SCA4) APC
Sign In for Pricing
View Details GTR15303563 1 Vial
Lentiviral mouse Dipk1b shRNA (UAS) - Lentiviral mouseDipk1b shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 
